Form 10-Q CYTORI THERAPEUTICS, For: Sep 30
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Cytori Therapeutics (CYTX) Misses Q3 EPS by 5c
November 7, 2014 7:57 AM ESTCytori Therapeutics (NASDAQ: CYTX) reported Q3 EPS of ($0.12), $0.05 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $3.16 million.
For earnings history and earnings-related data on Cytori Therapeutics (CYTX) click here.
... More